Develops and commercializes ophthalmic products for treating serious eye diseases. Focuses on innovation in drug delivery technologies and improving patient outcomes in eye care.
1987
United States
51 - 200 employees
Biotechnology
$25M - 100M in revenue
Not profitable
Total sustainability employees
2-3
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.